Merck’s 2Q net drops on higher costs, charges
By LINDA A. JOHNSON AP Business Writer Drugmaker Merck&Co. on Friday reported a 52 percent drop in second-quarter net income, weighed down by big restructuring charges from buying Schering-Plough Corp.,…
Read more on WXOW 19 La Crosse
Merck pares 2010 forecast, despite beat in quarter
By Ransdell Pierson
Merck pares 2010 forecast, despite beat in quarter
NEW YORK (Reuters) – Merck and Co issued a more cautious 2010 profit outlook on Friday and reported disappointing second-quarter sales of its vaccines and Singulair asthma drug, sending its shares down 2 percent.
Read more on Reuters
Related posts:
- Merck Announces Second-Quarter 2010 Financial Results
- GlaxoSmithKline reports Q2 loss on legal costs
- Pfizer profit slides on charges for Wyeth purchase – KMPH Fox 26
- Pfizer profit slides on charges for Wyeth purchase – The Associated Press
- Latest Generic Drugs News
Tags: charges, Costs, drops, higher, Merck's